No insider purchase over the last 90 days. The latest, by MADDALUNA ANTHONY J, was filed 29 Aug 2019.
Intec Pharma Ltd. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Intec Pharma Ltd. The previous disclosure was published on 4 February 2020.
Since 2019, the database holds 4 purchases and 4 sales by insiders of the company.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2020 · cache
8 of 8 declarations
Intec Pharma Ltd. is a biopharmaceutical company focused on developing innovative treatments for central nervous system disorders. It is listed on NASDAQ under the ticker symbol NTEC.